TRACON Pharmaceuticals Reports Regulatory Approval of Envafolimab in China
First Approval of a Subcutaneously Administered Checkpoint Inhibitor TRACON’s Pivotal U.S. Trial for Envafolimab in Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma...